4D Molecular Therapeutics, Inc.

FDMT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$149,336$249,108$52,351$153,001
Short-Term Investments$275,541$39,124$161,203$94,776
Receivables$0$0$700$47
Inventory$0$0$0$0
Other Curr. Assets$10,055$8,356$6,257$8,456
Total Curr. Assets$434,932$296,588$220,511$256,280
Property Plant & Equip (Net)$40,608$31,665$35,347$28,953
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$80,583$10,954$4,908$67,652
Tax Assets$0$0$0$0
Other NC Assets$4,261$684$1,080$602
Total NC Assets$125,452$43,303$41,335$97,207
Other Assets$0$0$0$0
Total Assets$560,384$339,891$261,846$353,487
Liabilities
Payables$4,386$3,515$3,322$4,764
Short-Term Debt$5,637$3,149$2,655$1,231
Tax Payable$0$0$0$0
Deferred Revenue$257$273$884$2,599
Other Curr. Liab.$18,869$12,014$8,870$7,744
Total Curr. Liab.$29,149$18,951$15,731$16,338
LT Debt$18,969$11,522$13,469$15,217
Deferred Rev, NC$1,057$972$1,076$2,491
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$603$617$233$334
Total NC Liab.$20,629$13,111$14,778$18,042
Other Liabilities$0$0$0$0
Cap. Leases$24,606$14,671$13,469$16,448
Total Liabilities$49,778$32,062$30,509$34,380
Equity
Pref Stock$0$0$0$0
Common Stock$5$4$3$3
Retained Earnings-$576,195-$415,327-$314,490-$206,996
AOCI$229$16-$1,196-$423
Other Equity$1,086,567$723,136$547,020$526,523
Total Equity$510,606$307,829$231,337$319,107
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$560,384$339,891$261,846$353,487
Net Debt-$124,730-$234,437-$36,227-$136,553